Director, Global Value & Access for Autoimmune (Hybrid)

Kite Pharma, Inc.

Parsippany-Troy Hills (NJ)

Hybrid

USD 206,000 - 266,000

Full time

7 days ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Medical insurance
Dental insurance
Vision insurance
Life insurance
Discretionary bonus
Stock-based incentives
Paid time off

Job summary

Kite Pharma, Inc. in the United States is seeking a Director, Global Value & Access Strategy (GVAS) for its autoimmune cell-therapy portfolio.

You will lead global market access strategies, shape payer evidence generation, and partner with HEOR, Medical Affairs and Commercial teams to support development and launch planning. The role requires cross-functional leadership across regions, strong communication with senior leadership, and the ability to influence decisions in a fast-paced portfolio.

Qualifications

  • 8+ years with a PhD/PharmD or 10+ years with MS/MA, MBA, PhD or equivalent advanced degree
  • 3+ years of direct experience supporting autoimmune disease programs, including development-stage assets, clinical strategy, market access, medical affairs, commercial strategy, or related functions
  • Strong understanding of global payer, pricing, reimbursement, and HTA landscapes
  • Experience supporting launch readiness activities, global launch planning, and lifecycle management

Responsibilities

  • Lead the development of global value and access strategies across the product lifecycle, from early development through launch and lifecycle management.
  • Provide market access input into target product profiles, clinical development plans, endpoint selection, comparator strategy, study design, and evidence generation plans.
  • Advise development teams on evidence requirements needed to support future reimbursement, pricing, and formulary access decisions.
  • Partner with HEOR, RWE, Medical Affairs, and Commercial teams to develop compelling value propositions and evidence packages.

Skills

Autoimmune market access
HEOR/RWE collaboration
Cross-functional leadership
Strategic thinking
Communication to leaders

Education

PhD/ PharmD
MS/MA/MBA/PhD
BS/BA

Job description

Kite Pharma, Inc. in the United States is seeking a Director, Global Value & Access Strategy (GVAS) for its autoimmune cell-therapy portfolio.

You will lead global market access strategies, shape payer evidence generation, and partner with HEOR, Medical Affairs and Commercial teams to support development and launch planning. The role requires cross-functional leadership across regions, strong communication with senior leadership, and the ability to influence decisions in a fast-paced portfolio.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global Access Director, Autoimmune Cell Therapies
Global Access Director, Autoimmune Cell Therapies

Kite Pharma, Inc. • San Francisco (CA)

Hybrid
USD 226,000 - 293,000
Global Value & Access Director, Autoimmune Cell Therapy
Global Value & Access Director, Autoimmune Cell Therapy

1110 Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 226,000 - 293,000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Global Value & Access Director, Autoimmune Cell Therapies
Global Value & Access Director, Autoimmune Cell Therapies

Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 206,000 - 293,000
Medical insurance
Dental insurance
Vision insurance
+2
Global Value & Access Director - Autoimmune Cell Therapy
Global Value & Access Director - Autoimmune Cell Therapy

Kite Pharma, Inc. • Thousand Oaks (CA)

Hybrid
USD 180,000 - 240,000
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • Thousand Oaks (CA)

Hybrid
USD 180,000 - 240,000
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 206,000 - 293,000
Medical insurance
Dental insurance
Vision insurance
+2
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

1110 Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 226,000 - 293,000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Director, US Payer & Value Marketing — CAR-T Access Strategy
Director, US Payer & Value Marketing — CAR-T Access Strategy

Kite Pharma • Santa Monica (CA)

Hybrid
USD 206,000 - 266,000
Discretionary annual bonus
Discretionary stock-based incentives
Paid time off
+1
Global Autoimmune CAR-T Medical Affairs Director
Global Autoimmune CAR-T Medical Affairs Director

Bristol-Myers Squibb Co • New Jersey

Hybrid
USD 207,000 - 251,000
Flexible Time Off
11 paid company holidays
Volunteer days
+1
Global Market Access Director, Vaccines
Global Market Access Director, Vaccines

Caraway Therapeutics, Inc. • United States

Hybrid
USD 191,000 - 300,000
Medical insurance
Dental insurance
Vision insurance
+2